Related references
Note: Only part of the references are listed.Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway
Michael J. Krisinger et al.
BLOOD (2012)
Reactive Astrocytes Overexpress TSPO and Are Detected by TSPO Positron Emission Tomography Imaging
Sonia Lavisse et al.
JOURNAL OF NEUROSCIENCE (2012)
Thrombin and hemin as central factors in the mechanisms of intracerebral hemorrhage-induced secondary brain injury and as potential targets for intervention
Ranjith Babu et al.
NEUROSURGICAL FOCUS (2012)
The complement component C5a receptor mediates pain and inflammation in a postsurgical pain model
De-Yong Liang et al.
PAIN (2012)
The Argatroban and Tissue-Type Plasminogen Activator Stroke Study Final Results of a Pilot Safety Study
Andrew D. Barreto et al.
STROKE (2012)
Anticoagulation With the Oral Direct Thrombin Inhibitor Dabigatran Does Not Enlarge Hematoma Volume in Experimental Intracerebral Hemorrhage
Arne Lauer et al.
CIRCULATION (2011)
Analysis of thrombin-antithrombin complex contents in plasma and hematoma fluid of hypertensive intracerebral hemorrhage patients after clot removal
C. -H. Wu et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Microglial C5aR (CD88) expression correlates with amyloid-β deposition in murine models of Alzheimer's disease
Rahasson R. Ager et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Inhibition of C5a receptor alleviates experimental CNS lupus
Alexander Jacob et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Transient Receptor Potential Canonical 3 (TRPC3) Mediates Thrombin-Induced Astrocyte Activation and Upregulates Its Own Expression in Cortical Astrocytes
Hisashi Shirakawa et al.
JOURNAL OF NEUROSCIENCE (2010)
C5a-Inhibitory Peptide Combined with Gabexate Mesilate Prevents the Instant Blood-Mediated Inflammatory Reaction in a Rat Model of Islet Transplantation
K. Tokodai et al.
TRANSPLANTATION PROCEEDINGS (2010)
Synergistic neuroprotective effects of C3a and C5a receptor blockade following intracerebral hemorrhage
Matthew C. Garrett et al.
BRAIN RESEARCH (2009)
The complement cascade as a therapeutic target in intracerebral hemorrhage
Andrew F. Ducruet et al.
EXPERIMENTAL NEUROLOGY (2009)
Attenuation of IgG immune complex-induced acute lung injury by silencing C5aR in lung epithelial cells
Lei Sun et al.
FASEB JOURNAL (2009)
Treatment with a C5aR Antagonist Decreases Pathology and Enhances Behavioral Performance in Murine Models of Alzheimer's Disease
Maria I. Fonseca et al.
JOURNAL OF IMMUNOLOGY (2009)
Complement Component C5a Mediates Hemorrhage-Induced Intestinal Damage
Sherry D. Fleming et al.
JOURNAL OF SURGICAL RESEARCH (2008)
A mouse model of intracerebral hemorrhage using autologous blood infusion
Michal A. Rynkowski et al.
NATURE PROTOCOLS (2008)
Sre kinase inhibition decreases thrombin-induced injury and cell cycle re-entry in striatal neurons
Da-Zhi Liu et al.
NEUROBIOLOGY OF DISEASE (2008)
Protective effect of C5a receptor inhibition after murine reperfused stroke
Grace H. Kim et al.
NEUROSURGERY (2008)
Complement induction in spinal cord microglia results in anaphylatoxin C5a-mediated pain hypersensitivity
Robert S. Griffin et al.
JOURNAL OF NEUROSCIENCE (2007)
Involvement of thrombin and mitogen-activated protein kinase pathways in hemorrhagic brain injury
Masatoshi Ohnishi et al.
EXPERIMENTAL NEUROLOGY (2007)
Cyclin D1, cdk4, and Bim are involved in thrombin-induced apoptosis in cultured cortical neurons
Haripriya Vittal Rao et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Thrombin induces striatal neurotoxicity depending on mitogen-activated protein kinase pathways in vivo
S. Fujimoto et al.
NEUROSCIENCE (2007)
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Michelle L. Block et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Thrombin-activatable procarboxypeptidase B regulates activated complement C5a in vivo
Toshihiko Nishimura et al.
BLOOD (2007)
The role of complement C3 in intracerebral hemorrhage-induced brain injury
Shuxu Yang et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2006)
Argatroban tPA stroke study -: Study design and results in the first treated cohort
Rebecca M. Sugg et al.
ARCHIVES OF NEUROLOGY (2006)
Role of complement component C5 in cerebral ischemia/reperfusion injury
Cristina Costa et al.
BRAIN RESEARCH (2006)
Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration
Trent M. Woodruff et al.
FASEB JOURNAL (2006)
Blockade of the complement C5a receptor reduces incisional allodynia, edema, and cytokine expression
J. David Clark et al.
ANESTHESIOLOGY (2006)
Generation of C5a in the absence of C3: a new complement activation pathway
Markus Huber-Lang et al.
NATURE MEDICINE (2006)
Thrombin-induced delayed injury involves multiple and distinct signaling pathways in the cerebral cortex and the striatum in organotypic slice cultures
S Fujimoto et al.
NEUROBIOLOGY OF DISEASE (2006)
Mechanisms of brain injury after intracerebral haemorrhage
GH Xi et al.
LANCET NEUROLOGY (2006)
Increased potency of a novel complement factor 5a receptor antagonist in a rat model of inflammatory bowel disease
TM Woodruff et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Systemic administration of Argatroban reduces secondary brain damage in a rat model of intracerebral hemorrhage: Histopathological assessment
T Nagatsuna et al.
CEREBROVASCULAR DISEASES (2005)
Thrombin inhibitor, argatroban, prevents tumor cell migration and bone metastasis
K Asanuma et al.
ONCOLOGY (2004)
Intracerebral hemorrhage in mice: Model characterization and application for genetically modified mice
T Nakamura et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2004)
Experimental intracerebral hemorrhage in the mouse - Histological, behavioral, and hemodynamic characterization of a double-injection model
L Belayev et al.
STROKE (2003)
Edema after intracerebral hemorrhage: correlations with coagulation parameters and treatment
LH Sansing et al.
JOURNAL OF NEUROSURGERY (2003)
Delayed argatroban treatment reduces edema in a rat model of intracerebral hemorrhage
T Kitaoka et al.
STROKE (2002)
Antiarthritic activity of an orally active C5a receptor antagonist against antigen-induced monarticular arthritis in the rat
TM Woodruff et al.
ARTHRITIS AND RHEUMATISM (2002)
Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products
FP Huang et al.
JOURNAL OF NEUROSURGERY (2002)
Role of thrombin in CNS damage associated with intracerebral haemorrhage - Opportunity for pharmacological intervention?
H Matsuoka et al.
CNS DRUGS (2002)
Share Paper
